# Stroke Reperfusion Injury

Recognize reperfusion injury after thrombolysis or thrombectomy by separating hemorrhagic transformation, malignant edema, and procedural complications; use serial neurologic examinations and urgent brain imaging to identify deterioration requiring blood pressure reassessment, intensive monitoring, and neurosurgical intervention.

**Clinical question:** How should clinicians recognize, monitor, and escalate care for reperfusion injury after acute ischemic stroke treatment?

Updated: 2026-08-21T02:04:11.095217+00:00

## What matters in practice
- After reperfusion therapy, new neurologic decline should trigger immediate evaluation for hemorrhagic transformation, cerebral edema, recurrent ischemia, and procedure-related complications; early recognition permits time-sensitive rescue measures. [11]
- Symptomatic intracranial hemorrhage after endovascular thrombectomy occurred in 6.72% across 25 cohort studies; older age, diabetes, higher presenting NIHSS score, and higher systolic blood pressure were associated predictors. [8]
- Parenchymal hematoma type 2 involving more than 30% of the infarcted lesion is the hemorrhagic-transformation subtype most strongly associated with neurologic deterioration, higher mortality, and poor 3-month outcome. [11]
- For malignant middle cerebral artery infarction, urgent neurosurgical assessment for decompressive hemicraniectomy is indicated; when selected, surgery is ideally performed within 48 hours of onset. [14]

## Triage neurologic deterioration after reperfusion

Treat abrupt decline after reperfusion as an intracranial emergency until imaging establishes the cause.

After intravenous thrombolysis or mechanical thrombectomy, promptly reassess any new or worsening focal deficit, reduced consciousness, headache, vomiting, or seizure with repeat NIHSS assessment and urgent noncontrast head CT. The immediate differential includes hemorrhagic transformation, large space-occupying infarction with edema, recurrent or persistent ischemia, and thrombectomy-related complications. [11]

Noncontrast CT remains the definitive test for distinguishing ischemic from hemorrhagic stroke in acute evaluation. When the CT does not explain ongoing deterioration and recurrent arterial occlusion or incomplete reperfusion remains plausible, obtain vascular imaging as dictated by the local acute-stroke pathway; CT perfusion has high sensitivity for ischemic stroke but is less reliable in reperfused stroke and lacunar infarction. [16][17]

Escalate patients with declining consciousness, radiographic mass effect, substantial hemorrhage, or concern for elevated intracranial pressure to a neurocritical-care setting and engage neurosurgery early. Reperfusion hemorrhage, cerebral edema, and large space-occupying infarcts are post-thrombectomy complications for which early recognition can enable lifesaving therapy. [11]
- Obtain urgent noncontrast CT for neurologic worsening after thrombolysis or thrombectomy. [11][16]
- Use serial NIHSS examinations to document objective deterioration; ECASS and SITS-MOST symptomatic hemorrhage definitions use clinical worsening of at least 4 NIHSS points with hemorrhage. [11]
- Review post-treatment systolic blood pressure, serum glucose, pre-treatment NIHSS score, age, diabetes, and infarct extent when estimating hemorrhagic risk. [8][19]

*Post-reperfusion deterioration patterns that change immediate disposition and imaging priorities. [11][14][16]*

| Clinical-radiographic pattern | Immediate next step | Why it matters |
| --- | --- | --- |
| New deficit or depressed consciousness with hemorrhage on noncontrast CT | Manage as suspected symptomatic intracranial hemorrhage in neurocritical care and reassess antithrombotic exposure. [11] | Hemorrhagic complications are a feared complication after thrombectomy and may be associated with substantial neurologic deterioration. [8][11] |
| Large territorial infarct with swelling, ventricular compression, cisternal effacement, or midline shift | Urgently involve neurosurgery for consideration of decompressive hemicraniectomy. [14] | Malignant middle cerebral artery infarction can require hemicraniectomy, ideally within 48 hours of onset in selected patients. [14] |
| Persistent or recurrent deficit without explanatory hemorrhage | Reassess for persistent or recurrent ischemia using the acute-stroke imaging pathway. [17] | Perfusion imaging may detect ischemia but has limitations after reperfusion. [17] |
| Neurologic decline with recent thrombectomy and no major intracranial finding | Assess for recognized mechanical-thrombectomy complications and continue close neurologic surveillance. [11] | Post-thrombectomy complications include reperfusion hemorrhage, cerebral edema, large infarcts, and access-site complications. [11] |

## Interpret hemorrhagic transformation by clinical and imaging severity

Do not equate every post-infarct blood product with symptomatic intracranial hemorrhage.

Hemorrhagic transformation is radiographic blood within infarcted brain and reflects blood-brain barrier disruption in ischemic tissue; reperfusion therapy can facilitate or amplify this process. Reperfusion injury includes oxidative stress, inflammatory activation, basal-lamina disruption, platelet and complement activation, and leukocyte infiltration, which together increase vascular permeability and bleeding risk. [13][18]

Classify the hemorrhage with a structured system such as the Heidelberg Bleeding Classification, while correlating the imaging finding with the neurologic examination. For clinical-impact assessment, ECASS and SITS-MOST definitions identify hemorrhage associated with at least a 4-point NIHSS worsening; this threshold is more likely to capture hemorrhage that affects long-term outcome than purely radiographic bleeding. [9][11]

Give particular weight to parenchymal hematoma type 2. A PH2 lesion occupying more than 30% of the infarcted area is the hemorrhagic-transformation subtype reported to significantly alter clinical course and is associated with neurologic deterioration, higher mortality, and poor 3-month outcome. [11]
- Distinguish petechial hemorrhagic infarction from a space-occupying parenchymal hematoma because management urgency and prognostic implications differ. [11]
- Interpret a worsening neurologic examination temporally linked to parenchymal hemorrhage as symptomatic hemorrhage rather than incidental radiographic transformation. [10][11]
- Maintain surveillance beyond the immediate procedure period: thrombus fragmentation and distal migration from a large clot burden may contribute to delayed bleeding complications after 24 hours. [13]

### Risk features that warrant heightened surveillance

Following endovascular thrombectomy, age, diabetes mellitus, higher initial NIHSS score, and higher systolic blood pressure were associated with symptomatic intracranial hemorrhage in a meta-analysis of 15,324 patients; pooled symptomatic hemorrhage incidence was 6.72%. These features should lower the threshold for frequent neurologic examinations and repeat imaging with any clinical change. [8]

Elevated systolic blood pressure after recanalization is biologically concerning because autoregulation is impaired in ischemic core and penumbra, and restored flow at higher systemic pressures may exacerbate reperfusion injury. Observational data associate higher post-thrombectomy systolic blood pressure with poorer outcomes, while randomized evidence has evaluated intensive versus standard post-reperfusion blood pressure control. [7][19]

*Hemorrhagic-transformation features that distinguish incidental imaging findings from high-risk clinical events. [10][11]*

| Feature | Interpretation | Clinical implication |
| --- | --- | --- |
| Hemorrhage with at least 4-point NIHSS worsening | Meets the clinical-worsening threshold used in ECASS and SITS-MOST symptomatic hemorrhage definitions. [11] | Treat as clinically consequential intracranial hemorrhage and intensify monitoring. [11] |
| PH2 involving more than 30% of the infarcted lesion | High-risk parenchymal hematoma subtype. [11] | Associated with neurologic deterioration, mortality, and poor 3-month outcome. [11] |
| Radiographic blood without temporal neurologic worsening | May represent asymptomatic hemorrhagic transformation rather than symptomatic hemorrhage. [10][11] | Continue clinical-imaging correlation rather than assigning prognosis from imaging alone. [10][11] |

## Identify malignant edema early enough for surgical rescue

Large infarcts can deteriorate from swelling even without clinically important hemorrhage.

After reperfusion, cerebral edema and large space-occupying infarction require active surveillance because they are recognized complications after mechanical thrombectomy and can cause coma or herniation. Repeat CT when consciousness worsens or the examination suggests rising intracranial pressure; imaging should assess infarct extent, sulcal effacement, ventricular compression, basal-cistern patency, and midline shift. [11][16]

A trial definition of malignant brain edema uses parenchymal hypodensity involving at least 50% of the middle cerebral artery territory plus local swelling, with midline shift of at least 5 mm at the septum pellucidum or pineal gland and obliteration of basal cisterns. These features should prompt urgent neurosurgical evaluation rather than continued observation alone. [10]

For selected patients aged 60 years or younger with malignant middle cerebral artery infarction, urgent neurosurgical assessment for decompressive hemicraniectomy is strongly recommended, with surgery ideally performed within 48 hours of stroke onset. In selected patients older than 60 years, hemicraniectomy may be considered after explicit appraisal of premorbid function and patient preferences. [14]
- Use serial level-of-consciousness examinations and repeat CT to detect evolving mass effect after a large territorial infarct. [10][11]
- Do not delay neurosurgical consultation until frank herniation when CT shows extensive middle cerebral artery infarction with swelling or shift. [10][14]
- Discuss the tradeoff between survival and post-stroke disability with surrogates when considering hemicraniectomy, especially for patients older than 60 years. [14]

*Imaging features supporting urgent evaluation for malignant brain edema. [10][14]*

| Imaging feature | Threshold or pattern | Action |
| --- | --- | --- |
| Territorial hypodensity | At least 50% of the middle cerebral artery territory. [10] | Assess urgently for malignant edema and mass effect. [10] |
| Midline shift | At least 5 mm at the septum pellucidum or pineal gland in a malignant-edema trial definition. [10] | Urgent neurosurgical evaluation. [10][14] |
| Local mass effect | Sulcal effacement, lateral-ventricle compression, or basal-cistern obliteration. [10] | Escalate monitoring and evaluate for decompressive surgery. [10][14] |

## Avoid physiologic contributors to secondary injury

Post-reperfusion monitoring should identify modifiable conditions linked to hemorrhage or infarct expansion.

Measure blood pressure frequently during the first 24 hours after thrombectomy or intravenous thrombolysis and address sustained elevation according to the active institutional acute-stroke protocol. Higher systolic blood pressure after thrombectomy is associated with poorer outcome, and higher systolic pressure is a predictor of symptomatic intracranial hemorrhage after thrombectomy. [8][19]

Avoid assuming that more intensive blood pressure lowering is automatically safer after successful reperfusion. Randomized trials have compared intensive versus standard post-reperfusion blood pressure strategies, and the appropriate target depends on the balance between hemorrhagic risk and perfusion dependence in injured tissue with impaired autoregulation. [7][19]

Check serum or capillary glucose as part of post-reperfusion surveillance, particularly in patients with diabetes. Diabetes predicted symptomatic intracranial hemorrhage after thrombectomy, and dysglycemia has been linked to blood-brain barrier injury that can aggravate hemorrhage after reperfusion. [8]
- Trend systolic blood pressure rather than relying on a single measurement; peak systolic pressure within 24 hours after thrombectomy has been studied as a marker of poor outcome. [19]
- Treat a rising blood pressure pattern together with worsening NIHSS as a trigger for immediate reassessment and head CT, not as an isolated vital-sign abnormality. [8][11][19]
- Review glucose in patients with neurologic deterioration or hemorrhagic transformation because dysglycemia may worsen blood-brain barrier injury. [8]

*Post-reperfusion monitoring variables with documented relevance to hemorrhagic or clinical outcome. [7][8][19]*

| Variable | Observed association | Operational response |
| --- | --- | --- |
| Systolic blood pressure | Higher systolic blood pressure predicted symptomatic intracranial hemorrhage after thrombectomy and has been associated with poorer post-thrombectomy outcome. [8][19] | Monitor frequently and use the current institutional reperfusion blood-pressure protocol. [7][19] |
| Initial NIHSS score | Higher presenting NIHSS was associated with symptomatic intracranial hemorrhage after thrombectomy. [8] | Use higher baseline severity to justify closer neurologic surveillance. [8] |
| Diabetes and glucose | Diabetes predicted symptomatic intracranial hemorrhage; dysglycemia may increase blood-brain barrier damage after reperfusion. [8] | Check glucose and incorporate diabetes into hemorrhage-risk assessment. [8] |

## Do not withhold indicated reperfusion solely because of reperfusion-injury risk

Reperfusion injury is a complication of restoring flow, not a reason to abandon time-dependent stroke treatment when eligibility is established.

Acute ischemic stroke treatment is time dependent: intravenous thrombolysis and endovascular therapy are intended to restore flow to potentially reversible hypoperfused tissue before infarction becomes established. The decision to reperfuse should therefore remain anchored in the acute-stroke eligibility assessment, imaging, and expected benefit rather than in nonspecific fear of hemorrhagic transformation. [1][6]

Reperfusion can produce hemorrhage and edema through blood-brain barrier disruption and inflammatory injury, but not all reperfused infarcts develop hematoma. Risk is increased by clinical features such as older age, diabetes, higher NIHSS score, and higher systolic pressure after thrombectomy; these factors support intensified post-treatment monitoring rather than retrospective therapeutic nihilism. [8][13]

When severe ipsilateral carotid stenosis is the likely source of a recent ischemic stroke, guideline-based practice favors revascularization within 2 weeks. This secondary-prevention decision is separate from management of acute reperfusion injury, but it should be revisited once the patient has stabilized and hemorrhagic or edema-related complications have been characterized. [2]
- Maintain rapid, coordinated stroke workflows because treatment delay reduces the opportunity to salvage reversibly ischemic tissue. [1][6]
- After successful recanalization, shift immediately from eligibility assessment to surveillance for hemorrhage, edema, recurrent ischemia, and access-site complications. [11]
- Reassess carotid revascularization timing after stabilization in patients with severe symptomatic carotid stenosis. [2]

*Clinical sequence for balancing reperfusion benefit with post-reperfusion harm. [1][2][6][11]*

| Phase | Decision focus | Action |
| --- | --- | --- |
| Hyperacute presentation | Potentially reversible ischemia | Use the organized acute-stroke pathway to evaluate eligibility for intravenous thrombolysis and endovascular treatment without treatment delay. [1][6] |
| Immediately after reperfusion | Hemorrhage, edema, and procedure-related complications | Perform serial neurologic assessments and obtain urgent noncontrast CT for clinical deterioration. [11][16] |
| After stabilization | Stroke mechanism and recurrence prevention | For severe symptomatic carotid stenosis, pursue revascularization planning within 2 weeks when appropriate. [2] |

## References
1. Guidelines for the Early Management of Patients With ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/str.0b013e318284056a
2. Postcarotid Endarterectomy Reperfusion Injury and ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/STROKEAHA.124.046437
3. Latest Articles | Stroke — www.ahajournals.org — https://www.ahajournals.org/journal/str/latest?startPage=0&pageSize=100
4. Futile and Harmful Reperfusion and the Balance Between ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/STROKEAHA.125.053226?doi=10.1161%2FSTROKEAHA.125.053226
5. Nature Index Hemorrhagic Transformation in Acute Ischemic Stroke — www.nature.com — https://www.nature.com/nature-index/topics/l4/hemorrhagic-transformation-in-acute-ischemic-stroke
6. Management of acute ischemic stroke - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S2387020623004679
7. Efficacy and Safety of Intensive Blood Pressure Lowering After Reperfusion Therapy in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S187887502400069X
8. Predictors of Symptomatic Intracranial Hemorrhage... : Cerebrovascular Diseases — journals.lww.com — https://journals.lww.com/00008999-202352040-00001
9. The Heidelberg Bleeding Classification : Stroke — journals.lww.com — https://journals.lww.com/doi/10.1161/strokeaha.115.010049
10. Study Details | NCT05920889 | Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies | ClinicalTrials.gov — clinicaltrials.gov — https://clinicaltrials.gov/study/NCT05920889
11. Complications of Mechanical Thrombectomy in Acute Ischemic Stroke — www.neurology.org — https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000012803
12. Blood–brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke | Neurology — www.neurology.org — https://www.neurology.org/doi/10.1212/WNL.0b013e3182697e70
13. Hemorrhagic Transformation After Ischemic Stroke: Mechanisms and Management - PMC — www.ncbi.nlm.nih.gov — http://www.ncbi.nlm.nih.gov/pmc/articles/8669478
14. Summary of the recommendations 2017 — extranet.who.int — https://extranet.who.int/ncdccs/Data/AUS_D1aia_Module%20IV%20Q1a%20Cliinical%20guidelines%20for%20Stroke%20Mgt%20SummaryOfRecommendations2017%20(1).pdf
15. Remote ischaemic conditioning for preventing and treating ... — www.cochranelibrary.com — https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012503.pub2/references/in
16. Part 7: The Era of Reperfusion : Section 2: Acute Stroke — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/circ.102.suppl_1.i-204
17. Use of Imaging to Guide Eligibility for Reperfusion ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/STROKEAHA.125.052748
18. Blood–Brain Barrier Disruption, Vascular Impairment, and ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/jaha.117.005819
19. Systolic Blood Pressure Within 24 Hours After Thrombectomy for Acute Ischemic Stroke Correlates With Outcome — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/jaha.117.006167

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.